Dr. Mary Spencer Deshields, MD

  • Vincennes, IN
  • Medical oncologist
NPI1952411795PAC ID0244120848
Medicare services, 2024
285
Medicare patients, 2024
133
Part D claims, 2024
433
Publications
4
Clinical trials
13
Practice address
520 S 7th St, Vincennes, IN 47591
Practice phone
Call (812) 882-5220
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Good Samaritan Hospital

Hospital · Vincennes, Indiana

See all 10 affiliations

Find Dr. Deshields' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mary Spencer Deshields is a medical oncologist in Vincennes, Indiana

Dr. Deshields practices at Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana.

Dr. Deshields' NPI, 1952411795, was assigned on August 30, 2006. Dr. Deshields graduated from Howard University College Of Medicine in 1986. Dr. Deshields holds Maryland license D47232.

NPI and contact details
Medicare PAC ID
0244120848
NPI enumeration date
August 30, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(812) 882-5220
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
66
Medical school graduation
1986

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mary Spencer Deshields practices at Good Samaritan Hospital in Vincennes, Indiana

Dr. Deshields' primary practice is Good Samaritan Hospital, at 520 S 7th St, Vincennes, IN 47591 in Knox County. The practice phone is (812) 882-5220.

Source: Dmand AI Affiliation Data

Dr. Mary Spencer Deshields is affiliated with 7 sites of care and 3 medical groups

Dr. Deshields' primary practice is Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana. Dr. Deshields is also affiliated with Daviess Community Hospital. The medical group on file is Good Samaritan Hospital Physicians Services. Dmand AI also links Dr. Deshields to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 hospice, each named with a free account.

See all 10 affiliations for Dr. Deshields

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mary Spencer Deshields' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deshields practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Good Samaritan HospitalAvailable with a free account
+6 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Deshields practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across State of Indiana and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mary Spencer Deshields is one of 72 medical oncologists in Indiana

Medical oncology is Dr. Deshields' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Deshields is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Deshields' licenses on file in 3 states: Maryland, Pennsylvania and Indiana.

Specialties and state licenses

  • Medical oncology, MarylandPrimaryLicense D47232 · 1995 to 2026 · taxonomy 207RX0202X
  • Pennsylvania license1990 to 2026
  • Indiana license2024 to 2025

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Deshields treats.

Medical oncologists near Dr. Deshields

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mary Spencer Deshields billed Medicare for 285 services in 2024

CMS data shows 285 Medicare services from Dr. Deshields across 5 procedure codes in 2024, all of them office visits, for 133 Medicare patients. Medicare paid $24,424 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024285
Medicare patients133
Paid by Medicare$24,424
Procedure codes5

Dr. Deshields' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4512024: 28537%

Dr. Deshields compared with the Indiana median for medical oncologists, 2024

  • Dr. Deshields
  • Indiana median
Medicare services
285vs 91469% below
Medicare patients
133vs 33660% below
Part D claims
300vs 65454% below

Medians across 72 medical oncologists in Indiana with Dmand AI profiles that report each measure.

Dr. Deshields' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Deshields

Need commercial claims for Dr. Deshields?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Deshields and other medical oncologists in Indiana.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mary Spencer Deshields treated 133 Medicare patients in 2024, average age 75

CMS counts 133 Medicare patients who saw Dr. Deshields in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deshields' median patient age at 70, with 56% women.

Medicare patients, 2024133
Average age75
Average risk score2.04
Also on Medicaid11%

Dr. Deshields' Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Deshields' Medicare patients by sex, 2024

  • Women7053%
  • Men6347%

Chronic conditions among Dr. Deshields' Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer53%
  4. Arthritis47%
  5. Ischemic heart disease41%
  6. COPD36%
  7. Chronic kidney disease33%
  8. Anxiety32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Deshields' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women56%
  • Men44%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mary Spencer Deshields wrote 433 Medicare Part D claims in 2024

In 2024, Dr. Deshields wrote 433 Medicare Part D claims for 105 patients. 79% of them were for generic drugs. CMS names the drug for 300 of them, across 14 drugs with 11 or more claims each, at $750,478 in total drug cost. In 2023, CMS named 430 claims across 18 drugs.

Part D claims, 2024433
Drugs named by CMS14
Total drug cost$750,478
Part D patients105

Dr. Deshields' Part D claims by kind of drug, 2024

  • Generic342 claims79%
  • Brand-name91 claims21%

Dr. Deshields' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Deshields' Part D claims, 2024

  • Opioids3%12 of 433 claims
  • Antibiotics3%12 of 433 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4302024: 30030%

Drugs named by CMS: 14 in 2024, 18 in 2023.

See all prescribing by Dr. Deshields

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Mary Spencer Deshields takes part in Medicare

Dr. Deshields accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Deshields by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mary Spencer Deshields has 4 publications on record

Dmand AI links 4 papers to Dr. Deshields. Dr. Deshields' most frequent co-author is Barbara Karen Dunn, MD.

Papers4

Dr. Deshields' most frequent co-authors

Recent publications by Dr. Deshields

See all 4 publications and co-authors

See who Dr. Deshields researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Deshields works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mary Spencer Deshields has worked on 13 clinical trials

Dmand AI links Dr. Deshields to 13 clinical trials, 10 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 7.

Clinical trials with Dr. Deshields by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 10Phase 3: 10 trials
  4. NonePhase 4: no trials

Conditions in Dr. Deshields' trials

  • Breast Neoplasms
  • Breast Diseases
  • Carcinoma, Intraductal, Noninfiltrating
  • Colonic Neoplasms
  • Breast Carcinoma In Situ

Investigators on the most trials with Dr. Deshields

Recent clinical trials with Dr. Deshields

See all 13 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Mary Spencer Deshields received $975 in industry payments from 2016 to 2025

CMS Open Payments shows 27 general payments to Dr. Deshields from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $167.

General payments to Dr. Deshields by program year, 2016 to 2025

General payments to Dr. Deshields by kind, 2016 to 2025

$975in total
  • Food and beverage$90292%
  • Education$738%

Companies that paid Dr. Deshields the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Deshields

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mary Spencer Deshields has 9 awards and honors on record

Dmand AI lists 9 awards for Dr. Deshields, most recently Home Town Hero Award in 2013.

Awards and honors for Dr. Deshields

  1. 2013
    • Home Town Hero Award
  2. 2010
    • Harriet Tubman Award for Outstanding Community Service
  3. 2004
    • Best Practices Award for Increasing Availability of Community Based Cancer Clinical Trials in Rural Maryland
  4. 1990
    • Clinical Fellow
    • Medical Dental Staff Award for Best Scientific Paper
  5. 1986
    • Alpha Omega Alpha
See all 9 awards

Source: Dmand AI Professional Profile Data

Dr. Mary Spencer Deshields graduated from Howard University College Of Medicine

Dr. Deshields graduated from Howard University College Of Medicine in 1986.

  1. Medical schoolHoward University College Of Medicine
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Mary Spencer Deshields accepts plans from 12 insurance carriers

Dr. Deshields is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

Plan types Dr. Deshields accepts, by number of carriers

  1. Medicare9
  2. PPO8
  3. HMO5
  4. POS4
  5. EPO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Mary Spencer Deshields's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mary Spencer Deshields

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mary Spencer Deshields' NPI number?

Dr. Mary Spencer Deshields' NPI number is 1952411795. It was assigned on August 30, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mary Spencer Deshields?

Dr. Mary Spencer Deshields is a medical oncologist in Vincennes, Indiana. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Mary Spencer Deshields practice?

Dr. Deshields practices at 520 S 7th St, Vincennes, IN 47591. Dr. Deshields' primary practice is Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana. Dmand AI also links Dr. Deshields to 2 hospitals, 2 group practices and clinics, 2 medical groups and 1 hospice.

What is Dr. Mary Spencer Deshields' office phone number?

The practice phone on file for Dr. Deshields is (812) 882-5220.

What is Dr. Mary Spencer Deshields' medical license number?

Dr. Deshields holds Maryland license D47232, one of the licenses on file in 3 states.

Which states has Dr. Mary Spencer Deshields been licensed in?

Dmand AI has state licenses on file for Dr. Deshields in Maryland (1995 to 2026), Pennsylvania (1990 to 2026) and Indiana (2024 to 2025).

Which hospitals is Dr. Mary Spencer Deshields affiliated with?

Dr. Deshields practices at Good Samaritan Hospital in Vincennes, Indiana. Dr. Deshields is also affiliated with Daviess Community Hospital. Dmand AI links Dr. Deshields to 2 more hospitals.

What medical group is Dr. Mary Spencer Deshields part of?

Dr. Deshields is linked to Good Samaritan Hospital Physicians Services. Dmand AI links Dr. Deshields to 2 more medical groups.

Does Dr. Mary Spencer Deshields accept Medicare?

Yes. CMS data shows Dr. Deshields billed Medicare for 285 services in 2024, and Dr. Deshields accepts Medicare assignment.

How many Medicare patients does Dr. Mary Spencer Deshields see?

CMS counts 133 Medicare patients who saw Dr. Deshields in 2024, with an average age of 75.

Show 9 more questionsShow fewer questions

Is Dr. Mary Spencer Deshields board certified?

Yes. Dr. Deshields is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Mary Spencer Deshields bill to Medicare?

In 2024, Dr. Deshields' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).

Where did Dr. Mary Spencer Deshields go to medical school?

Dr. Deshields graduated from Howard University College Of Medicine in 1986.

What drugs does Dr. Mary Spencer Deshields prescribe most?

In 2024 Medicare Part D data, Dr. Deshields' most prescribed drugs by claims were Abiraterone Acetate, Imbruvica and Prochlorperazine Maleate.

Has Dr. Mary Spencer Deshields received payments from drug or device companies?

CMS Open Payments shows $975 in general payments to Dr. Deshields from 16 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Mary Spencer Deshields been practicing?

Dr. Deshields graduated from medical school in 1986, 40 years ago.

Does Dr. Mary Spencer Deshields do research?

Dmand AI links 4 publications to Dr. Deshields. Dr. Deshields has worked on 13 clinical trials.

Who does Dr. Mary Spencer Deshields publish with?

Dr. Deshields' most frequent co-authors are Barbara Karen Dunn, MD (1 shared paper).

What insurance does Dr. Mary Spencer Deshields accept?

Dr. Deshields is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Indiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)